Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients
- PMID: 15201761
- DOI: 10.1097/01.ju.0000128574.50588.97
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients
Abstract
Purpose: Previous studies have demonstrated that obesity can increase the risk of stone formation as well as recurrence rates of stone disease. Yet appropriate medical management can significantly decrease the risk of recurrent stone disease. Therefore, we analyzed our obese patient population, assessing the risk factors for stone formation and the impact of selective medical therapy on recurrent stone formation.
Materials and methods: A retrospective chart review was performed to identify obese patients with stone disease from our Stone Center. Metabolic risk factors for stones were identified as well as patient response to medical therapy. A similar analysis was performed on a group of age and sex matched nonobese stone formers.
Results: Of 1,021 patients 140 (14%) were identified as obese (body mass index greater than 30). Of these patients complete metabolic evaluations were available in 83 with an average followup of 2.3 years. The most common presenting metabolic abnormalities among these obese patients included gouty diathesis (54%), hypocitraturia (54%) and hyperuricosuria (43%), which presented at levels that were significantly higher than those of the nonobese stone formers (p <0.05). Stone analysis was available in 32 obese patients with 63% having uric acid calculi. After initiating treatment with selective medical therapy obese and nonobese patients demonstrated normalization of metabolic abnormalities, resulting in an average decrease in new stone formation from 1.75 to 0.15 new stones formed per patient per year in both groups.
Conclusions: Obesity, as a result of dietary indiscretion, probable purine gluttony and possible type II diabetes, appears to have a significant role in recurrent stone formation. Appropriate metabolic evaluation, institution of medical therapy and dietary recommendations to decrease animal protein intake can significantly improve the risk of recurrent stone formation in these often difficult to treat patients.
Similar articles
-
Metabolic abnormalities associated with calyceal diverticular stones.BJU Int. 2006 May;97(5):1053-6. doi: 10.1111/j.1464-410X.2006.06134.x. BJU Int. 2006. PMID: 16643491
-
Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.J Urol. 2008 Feb;179(2):570-4. doi: 10.1016/j.juro.2007.09.040. Epub 2007 Dec 21. J Urol. 2008. PMID: 18078957
-
Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.J Urol. 2009 Mar;181(3):1145-50. doi: 10.1016/j.juro.2008.11.014. Epub 2009 Jan 18. J Urol. 2009. PMID: 19152932
-
[Functional evaluation in patients with kidney calculi].Srp Arh Celok Lek. 1998 Sep-Oct;126(9-10):394-8. Srp Arh Celok Lek. 1998. PMID: 9863414 Review. Serbian.
-
[Treatment of reno-ureteral lithiasis with ESWL in obese patients. Apropos of 150 patients].Arch Esp Urol. 2003 Oct;56(8):933-8. Arch Esp Urol. 2003. PMID: 14639849 Review. Spanish.
Cited by
-
Obesity Is Positively Associated and Alcohol Intake Is Negatively Associated with Nephrolithiasis.Nutrients. 2022 Oct 4;14(19):4122. doi: 10.3390/nu14194122. Nutrients. 2022. PMID: 36235774 Free PMC article.
-
Stone formation and management after bariatric surgery.Nat Rev Urol. 2015 May;12(5):263-70. doi: 10.1038/nrurol.2015.67. Epub 2015 Apr 7. Nat Rev Urol. 2015. PMID: 25850790 Review.
-
Urinary stone disease and obesity: Different pathologies sharing common biochemical mechanisms.World J Nephrol. 2012 Feb 6;1(1):12-5. doi: 10.5527/wjn.v1.i1.12. World J Nephrol. 2012. PMID: 24175237 Free PMC article. Review.
-
The effectiveness of citrates and pyridoxine in the treatment of kidney stones.J Med Life. 2023 Jun;16(6):856-861. doi: 10.25122/jml-2023-0234. J Med Life. 2023. PMID: 37675156 Free PMC article. Review.
-
[Diagnosis and treatment of nephrolithiasis. What is established?].Internist (Berl). 2015 Dec;56(12):1361-8. doi: 10.1007/s00108-015-3758-0. Internist (Berl). 2015. PMID: 26530696 Review. German.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources